Multivitamins Lead to Fewer Neuropathy Symptoms.
There's evidence that consumption of multivitamins is linked to fewer symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients. *
"Chemotherapy-induced peripheral neuropathy (CIPN) can interfere with daily function and quality of life, and there are no known preventive approaches," observed Gary R. Zirpoli and colleagues in their recent study.
The study included 1,225 subjects enrolled in a clinical trial in which they received the drug paclitaxel. Questionnaire responses provided information concerning the use of supplements before and at diagnosis. A second questionnaire administered at six months provided information regarding supplement use during treatment.
Multivitamin use prior to breast cancer diagnosis was associated with significantly lower CIPN symptoms, while the use of multivitamin supplements during treatment was associated with a marginal decrease. The researchers recommend prospective randomized trials of vitamin supplementation to confirm their findings.
Editor's Note: "Multiple studies demonstrate that the majority of cancer patients and survivors use multivitamins and other dietary supplements," noted Jennifer A. Ligibel, M.D., of Dana-Farber Cancer Institute in an accompanying editorial. "A review of 32 studies demonstrated that 64% to 81% of cancer patients and survivors overall, and 67% to 87% of breast cancer patients specifically, used dietary supplements after cancer diagnosis."
* J Natl Cancer Inst. 2017 Dec 1;109(12).
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||In The News|
|Article Type:||Brief article|
|Date:||Aug 1, 2018|
|Previous Article:||Higher Omega-3 Linked to Lower Mortality Risk.|
|Next Article:||Nearly Half of Cancer Deaths Caused by Bad Lifestyle Choices.|